Impavido Capsule
Product Images NDC 69051-300

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Impavido (NDC 69051-300). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Profounda, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Chemical structure of miltefosine shown as a molecular diagram with depicted carbon chains and phosphate group, corresponding to the active ingredient in IMPAVIDO 50 mg capsules by Profounda, Inc.*

FDA Label Image

Principal Display Panel (Carton)

FDA Label Image

Image 03

Packaging label for Impavido (miltefosine) capsules, 50 mg per capsule, supplied by Profounda, Inc. The label indicates an oral dosage form with 28 capsules per container. It includes storage instructions, active and inactive ingredients, distribution information, a barcode, lot number, and expiration date details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.